Cox Troy purchased $149K of MPLT (indirect holdings)
Cox Troy purchased 15,620 indirectly-held shares of MapLight Therapeutics, Inc. (MPLT) at $9.52 ($0.15M total) on 2026-07-28.
How this was made
The 30-second read
Why it matters
The newest concrete fact is the disclosed open-market purchase size, price, and post-transaction holdings; it may slightly improve sentiment but does not change fundamentals based on the provided text.
Market read
Useful for tracking insider behavior, but the filing alone is unlikely to drive a tradable repricing without additional company-specific catalysts.
What to watch
The transaction is described as indirect and not tied to a 10b5-1 plan; without context on prior trades or intent, traders should avoid over-weighting it.
Background
The article is a primary-source SEC Form 4 insider transaction for MapLight Therapeutics, Inc.
Ticker impact
MapLight Therapeutics director Cox Troy filed a Form 4 open-market purchase of 15,620 shares at $9.5200 on 2026-07-28.
Likely limited near-term impact; any effect would be sentiment-driven and small.
The filing is a routine insider transaction with no accompanying guidance, deal, or operational update in the text.
Market effects
No sector-level read-across is provided beyond a single insider transaction.
None indicated.
None indicated.
Counterpoint
Insider open-market buys can be driven by diversification, liquidity needs, or pre-planned activity, so signal strength may be weak.
Key entities
- issuerMapLight Therapeutics, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderCox Troy
Director who purchased 15,620 shares indirectly at $9.5200/share.